Sotera Health SHC
NASDAQ SHC
$19.47 -0.07 (-0.36%)
As of: Aug 27, 2026 · 3:59 PM EDT

Sotera Health (SHC) Asset Writedowns and Impairment (2022)

Sotera Health (SHC) posted quarterly Asset Writedowns and Impairment of $9.6 million for Q2 2022.

Sotera Health (SHC) Asset Writedowns and Impairment (2022) Analysis & Trends

Sotera Health's Asset Writedowns and Impairment history runs 1 years deep, the most recent figure standing at $9.6 million for Q2 2022.

  • In Q2 2022, Asset Writedowns and Impairment changed N/A year-over-year to $9.6 million; the TTM figure through Jun 2023 stood at $9.6 million (changed 0.0% YoY), while the FY2022 annual figure was $9.6 million, changed N/A from the prior year.
  • Asset Writedowns and Impairment for Q2 2022 stood at $9.6 million.
  • The five-year high for Asset Writedowns and Impairment was $9.6 million in Q2 2022, with the low at $9.6 million in Q2 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 234.15 Bn 230.09 Bn 8.34 Bn
2 Danaher 152.10 Bn 147.75 Bn 3.61 Bn
3 Natera 48.48 Bn 47.38 Bn 486.15 Mn
4 Agilent Technologies 44.35 Bn 42.55 Bn 990.00 Mn
5 Iqvia Holdings 43.68 Bn 41.60 Bn 1.44 Bn
6 Idexx Laboratories 43.02 Bn 42.83 Bn 779.09 Mn
7 Illumina 34.39 Bn 33.22 Bn 770.00 Mn
8 Mettler Toledo International 28.29 Bn 28.24 Bn 650.22 Mn
9 Labcorp Holdings 27.51 Bn 27.37 Bn 1.11 Bn
10 Sotera Health 5.58 Bn 5.22 Bn 177.96 Mn

Historic Data

Download Data
DateValue
Jun 30, 2022 9.60 Mn
Jun 30, 2022 9.60 Mn